QA: Ernexa Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000748592_2019_Ernexa_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000748592, Ernexa Therapeutics Inc

  xvar xval
0 AssetsCurrent 6,785,000
1 IntangibleAssetsNetIncludingGoodwill 667,000
2 PropertyPlantAndEquipmentNet 4,667,000
3 remainder_Assets 2,745,000
4 LiabilitiesCurrent 4,024,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,923,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,583,759
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 8,761,994
11 remainder_Revenues 23,348,736
12 remainder_NetIncome 322,937
13 remainder_ComprehensiveNetIncome -17,454
  yvar yval
0 Assets 14,864,000
1 Liabilities 7,947,000
2 Expenses 23,345,753
3 Revenues 23,348,736
4 StockholdersEquity 6,917,000
5 NetIncome 325,920
6 ComprehensiveNetIncome 317,193
7 BaseVar 34,922,940
8 EconomicCapitalRatiobeforeLimitedLiability 1.35
9 EconomicCapitalRatio 2.57

Edgar->Model Mapping

Feature Distribution

Change over Time